Beijing SL Pharmaceutical Co., Ltd. (SHE:002038)
China · Delayed Price · Currency is CNY 5.75
-0.15 (-2.54%)
Sep 10, 2026, 12:14 PM CST
Beijing SL Pharmaceutical Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 570.26 | 623.64 | 660.42 | 1,018 | 1,050 | 1,215 |
Revenue Growth | -0.52% | -5.57% | -35.15% | -3.03% | -13.55% | 9.17% |
Gross Profit Gross Profit Growth | 348.31 | 386.77 | 448.33 | 829.55 | 893.21 | 1,031 |
Operating Income Operating Income Growth | -22.41 | -7.68 | 27.65 | 220.1 | 143.66 | 212.3 |
Net Income Net Income Growth | -723.32 | -347.2 | -74.07 | 416.69 | 234.4 | 425.94 |
Earnings Per Share EPS Growth | -0.70 | -0.34 | -0.07 | 0.41 | 0.23 | 0.41 |
EPS Growth | - | - | - | 78.26% | -43.90% | 13.89% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Industry Pharmaceutical Industry Growth | 612.49 | 652.74 | 1,005 | 1,033 | 1,215 |
Unallocated Others Unallocated Others Growth | 11.15 | 7.68 | 12.98 | 17.05 | - |
Total Total Growth | 623.64 | 660.42 | 1,018 | 1,050 | 1,215 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,236 | 1,141 | 1,982 | 2,133 | 1,453 | 1,636 |
Total Debt Total Debt Growth | - | - | - | - | - | 2.47 |
Net Cash (Debt) Net Cash Growth | 1,236 | 1,141 | 1,982 | 2,133 | 1,453 | 1,634 |
Net Cash Growth | -35.55% | -42.42% | -7.07% | 46.77% | -11.06% | 13.67% |
Net Cash Per Share Net Cash Per Share Growth | 1.20 | 1.12 | 1.87 | 2.10 | 1.43 | 1.57 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 558.39 | 257.66 | 225.49 | 460.2 | 389.82 | 464.63 |
Capital Expenditures CapEx Growth | -64.56 | -192.97 | -347.38 | -218.36 | -163.49 | -236.91 |
Free Cash Flow Free Cash Flow Growth | 493.83 | 64.69 | -121.89 | 241.84 | 226.33 | 227.72 |
Free Cash Flow Growth | - | - | - | 6.85% | -0.61% | 42.42% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 61.08% | 62.02% | 67.89% | 81.46% | 85.05% | 84.89% |
Operating Margin | -3.93% | -1.23% | 4.19% | 21.61% | 13.68% | 17.48% |
Pretax Margin | -124.83% | -44.60% | -20.25% | 45.65% | 24.70% | 37.69% |
Profit Margin | -126.84% | -55.67% | -11.21% | 40.92% | 22.32% | 35.06% |
FCF Margin | 86.60% | 10.37% | -18.46% | 23.75% | 21.55% | 18.75% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.010 | 0.010 | 0.020 | 0.150 | 0.100 | 0.100 |
Dividend Per Share Growth | -50.00% | -50.00% | -86.67% | 50.00% | 0% | 0% |
Dividend Yield | 0.17% | 0.14% | 0.27% | 1.51% | 1.26% | 0.97% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | 25.12 | 36.03 | 26.07 |
Forward PE | - | 19.74 | 19.74 | 30.88 | 12.35 | 12.35 |
P/FCF Ratio | 12.27 | 117.04 | - | 43.29 | 37.31 | 48.77 |
PS Ratio | 10.63 | 12.14 | 11.62 | 10.28 | 8.04 | 9.14 |